Needham & Company Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Getting Some Mojo Back

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Needham & Company Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Getting Some Mojo Back

Jefferies Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Q2 Bottoms Out; Q3 Rebound with Leuco

September 10, 2012 7:49 AM EDT

Jefferies maintains a 'Buy' on Sagent Pharmaceuticals (NASDAQ: SGNT) price target of $23.00.

Analyst, Corey Davis, said, "Sagent's execution has been disappointing, and lowered guidance in Aug. bottomed the stock at $13. Although management needs to execute, we do see a quick stock rebound due to: 1)... More